Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 977-986

  Li, Bin ^a   Duysen, Ellen G ^a   Volpicelli Daley, Laura A ^b   Levey, Allan I ^b   Lockridge, Oksana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholinesterase; Knockout mice; Muscarinic receptor; Oxotremorine; Pilocarpine; Seizures

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR; MESSENGER RNA; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; OXOTREMORINE; PILOCARPINE;

ANALGESIA; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TREMOR; WESTERN BLOTTING;

EID: 0037346942     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00022-4     Document Type: Article

References (47)

1. Ben-Barak J., Dudai Y. Scopolamine induces an increase in muscarinic receptor level in rat hippocampus. Brain Res. 193:1980;309-313.
2. Bernard V., Laribi O., Levey A.I., Bloch B. Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation. J. Neurosci. 18:1998;10207-10218.
3. Bernard V., Levey A.I., Bloch B. Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation. J. Neurosci. 19:1999;10237-10249.
4. Bernard V, Brana C, Liste I, Lockridge O, Bloch B. Dramatic depletion of cell surface muscarinic acetylcholine receptor M2R due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase (AChE) deficient mice. Cholinergic Mechanism Symposium, in press.
5. Bohm S.K., Grady E.F., Bunnett N.W. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322:1997;1-18.
6. Bruce R.D. A confirmatory study of the up-and-down method for acute oral toxicity testing. Fundam. Appl. Toxicol. 8:1987;97-100.
7. Bushnell P.J., Kelly K.L., Ward T.R. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance. J. Pharmacol. Exp. Ther. 270:1994;15-25.
8. Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50:1998;279-290.
9. Costa L.G., Schwab B.W., Murphy S.D. Tolerance to anticholinesterase compounds in mammals. Toxicology. 25:1982;79-97.
10. Duttaroy A., Gomeza J., Gan J.W., Siddiqui N., Basile A.S., Harman W.D.et al. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol. Pharmacol. 62:2002;1084-1093.
11. Duysen E.G., Li B., Xie W., Schopfer L.M., Anderson R.S., Broomfield C.A.et al. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 299:2001;528-535.
12. Duysen E.G., Stribley J.A., Fry D.L., Hinrichs S.H., Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res. Dev. Brain Res. 137:2002;43-54.
13. Edwardson J.M., Szekeres P.G. Endocytosis and recycling of muscarinic receptors. Life Sci. 64:1999;487-494.
14. Eglen R.M. Muscarinic receptors and gastrointestinal tract smooth muscle function. Life Sci. 68:2001;2573-2578.
15. Eisenach J.C. Muscarinic-mediated analgesia. Life Sci. 64:1999;549-554.
16. Fukamauchi F., Saunders P.A., Hough C., Chuang D.M. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol. Pharmacol. 44:1993;940-949.
17. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;15312-15317.
18. Gomeza J., Shannon H., Kostenis E., Felder C., Zhang L., Brodkin J.et al. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1692-1697.
19. Gomeza J., Zhang L., Kostenis E., Felder C., Bymaster F., Brodkin J.et al. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10483-10488.
20. Gray E.G., Whittaker V.P. The isolation of nerve endings from brain: an electron microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96:1962;79-88.
21. Gupta R.C., Patterson G.T., Dettbarn W.D. Mechanisms of toxicity and tolerance to diisopropylphosphorofluoridate at the neuromuscular junction of the rat. Toxicol. Appl. Pharmacol. 84:1986;541-550.
22. Haddad E.B., Rousell J., Mak J.C., Barnes P.J. Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line. Br. J. Pharmacol. 116:1995;2027-2032.
23. Hamilton S.E., Loose M.D., Qi M., Levey A.I., Hille B., McKnight G.S.et al. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13311-13316.
24. 3H-quinuclidinyl benzilate binding and protein synthesis in the striatum following chronic administrations of muscarinic agonist. Jpn. J. Pharmacol. 67:1995;83-86.
25. Janossy A., Saez J.M., Li J.Y. Carbachol induces homologous steroidogenic refractoriness of bovine fasciculata-reticularis cells. Mol. Cell. Endocrinol. 172:2001;147-155.
26. Johns R.J., McQuillen M.P. Syndromes simulating myasthenia gravis: asthenia with anticholinesterase tolerance. Ann. N.Y. Acad. Sci. 135:1966;385-397.
27. Koenig J.A., Edwardson J.M. Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol. Pharmacol. 49:1996;351-359.
28. Konig M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J.et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 383:1996;535-538.
29. Lenz W., Petrusch C., Jakobs K.H., van Koppen C.J. Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady-state levels. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;507-513.
30. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11:1991;3218-3226.
31. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P.et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75:2000;1320-1331.
32. Liste I., Bernard V., Bloch B. Acute and chronic acetylcholinesterase inhibition regulates in vivo the localization and abundance of muscarinic receptors m2 and m4 at the cell surface and in the cytoplasm of striatal neurons. Mol. Cell. Neurosci. 20:2002;244-256.
33. Logsdon C.D. The influence of the cellular context on receptor function: a necessary consideration for physiologic interpretations of receptor expression studies. Life Sci. 64:1999;369-374.
34. Matsui M., Motomura D., Karasawa H., Fujikawa T., Jiang J., Komiya Y.et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9579-9584.
35. Messer W.S. Jr., Bohnett M., Stibbe J. Evidence for a preferential involvement of M1 muscarinic receptors in representational memory. Neurosci. Lett. 116:1990;184-189.
36. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience. 110:2002;627-639.
37. Mileson B.E., Chambers J.E., Chen W.L., Dettbarn W., Ehrich M., Eldefrawi A.T.et al. Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol. Sci. 41:1998;8-20.
38. Peterson G.L., Schimerlik M.I. Large scale preparation and characterization of membrane-bound and detergent-solubilized muscarinic acetylcholine receptor from pig atria. Prep. Biochem. 14:1984;33-74.
39. Roseberry A.G., Bunemann M., Elavunkal J., Hosey M.M. Agonist-dependent delivery of M(2) muscarinic acetylcholine receptors to the cell surface after pertussis toxin treatment. Mol. Pharmacol. 59:2001;1256-1268.
40. Russell R.W., Carson V.G., Booth R.A., Jenden D.J. Mechanisms of tolerance to the anticholinesterase, DFP: acetylcholine levels and dynamics in the rat brain. Neuropharmacology. 20:1981;1197-1201.
41. 3H)-quinuclidinyl benzilate associated with chronically low acetylcholinesterase activity. Life Sci. 24:1979;1159-1163.
42. Tobin A.B., Nahorski S.R. Rapid agonist-mediated phosphorylation of m3-muscarinic receptors revealed by immunoprecipitation. J. Biol. Chem. 268:1993;9817-9823.
43. Tsuga H., Kameyama K., Haga T., Honma T., Lameh J., Sadee W. Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2. J. Biol. Chem. 273:1998;5323-5330.
44. van der Zee E.A., Luiten P.G. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog. Neurobiol. 58:1999;409-471.
45. Waugh M.G., Challiss R.A., Berstein G., Nahorski S.R., Tobin A.B. Agonist-induced desensitization and phosphorylation of m1-muscarinic receptors. Biochem. J. 338:1999;175-183.
46. Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D.et al. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293:2000;896-902.
47. Yagle K., Costa L.G. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat. Neurotoxicology. 17:1996;523-530.